Epelmycin B

Epelmycin B has anti-Gram positive, negative bacteria and candida albicans activity, and has anti-leukemic L1210 activity, which is stronger than Aclacinomycin[1].

Product Specifications

CAS Number

[107807-24-9]

UNSPSC

12352005

Target

Bacterial; Fungal

Related Pathways

Anti-infection

Field of Research

Cancer; Infection

Smiles

O=C1C2=C(C(O)=CC=C2)C(C3=C1C(O)=C(C4=C3O)[C@@]([H])(C(OC)=O)[C@@](CC)(C([H])([C@@]4(O[C@]5(C([H])([C@@H]([C@](O[C@]6(C([H])([C@@H]([C@](O[C@@]7(O[C@@]8([H])C)[H])([C@](C)(O6)[H])[H])O[C@]7(C([H])(C8=O)[H])[H])[H])[H])([C@](C)(O5)[H])[H])N(C)C)[H])[H])[H])[H])O)=O

Molecular Formula

C42H51NO16

Molecular Weight

825.85

References & Citations

[1]O Johdo, et al. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730. J Antibiot (Tokyo) . 1991 Oct;44 (10) :1121-9.